Brukinsa (zanubrutinib)

pCPA File Number: 22458
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of adult patients with chronic lymphocytic leukemia (CLL).
Sponsor/Manufacturer:
BeiGene, Ltd.
CDA-AMC Project Number:
PC0310
pCPA Engagement Letter Issued:
Negotiation Process Concluded: